Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering
-
OTORIO's Midyear Report Reveals Alarming Trends and Proactive Strategies in OT-IoT-CPS Security
-
Open Lending to Announce Second Quarter 2024 Results on August 8, 2024
-
Atossa Therapeutics Completes Enrollment of 80mg Pharmacokinetic Run-In Cohort in Phase 2 EVANGELINE Clinical Trial Evaluating (Z)-Endoxifen as a Neoadjuvant Treatment for ER+ / HER2- Breast Cancer
-
RSports Interactive Acquires GameBlazers, a Next Generation Daily Fantasy Sports Gaming Company and Collectible Trading Platform
-
Exela Technologies and AIDEO Technologies Enter Strategic Alliance
-
Connexa Regains Full Nasdaq Compliance
-
HOOKIPA Pharma Announces Leadership Changes to Intensify Focus on HB-200
-
NANO Nuclear Energy Appoints Distinguished Nuclear Regulatory Expert David Tiktinsky as Head of Nuclear Regulatory Licensing after nearly 40-years with the Nuclear Regulatory Commission (NRC)
-
OTORIO's Midyear Report Reveals Alarming Trends and Proactive Strategies in OT-IoT-CPS Security
-
HeartCore to Authorize Second Dividend Payment
-
CSW Industrials Announces Date for Fiscal First Quarter 2025 Earnings Release Conference Call
-
Vericel Announces Appointment of Karen Mahoney as Chief Human Resources Officer
-
Willis Lease Finance Corporation Hires SR Technics Veteran, Caroline M. Vandedrinck, to Run its Growing Services Businesses
-
Novo Nordisk A/S - share repurchase programme
-
SciSparc: MitoCareX Confirms Potential Significant Role of its Drug Target in Non-Small Cell Lung Cancer
-
MIMEDX Announces Publication Focused on Surgical Applications Using MIMEDX Placental-Based Allografts in Nature – Scientific Reports
-
Hill International Selected to Manage Capital Improvement Program for Los Angeles World Airports
-
Catalyst Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 7, 2024
-
BDC Capital Inc. disposes of Common Shares of Profound Medical Corp.
-
Pomerantz LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of Stock of Y-mAbs Therapeutics, Inc. - YMAB
-
Franklin Electric Declares Quarterly Dividend of $0.25 Per Share
-
AMG to Announce Second Quarter Results on July 29, 2024
-
Saudi Arabia’s General Authority of Civil Aviation and Lilium sign MoU to collaborate on development and implementation of eVTOL regulation in the Kingdom
-
Emergent BioSolutions Announces Shelf-Life Extension for NARCAN® Nasal Spray in Canada
-
Spectral Medical Inc. Announces Closing of Additional US$1 Million Convertible Notes
-
STRATA Skin Sciences Announces Approval of XTRAC Momentum™ 1.0 Device in Japan
-
UNITY Biotechnology Announces Appointment of Alicia Tozier as Chief Strategy Officer
-
DLH to Announce Fiscal 2024 Third Quarter Financial Results
-
Vittoria Biotherapeutics Announces Peer-Reviewed Publication in Science Immunology
-
Ekso Bionics to Report Second Quarter 2024 Financial Results on July 29, 2024
-
ManTech Wins Spot on $8 Billion FBI BPA Contract
-
PhlattLine Launches the First Organizational Development-as-a-Service (ODaaS), Providing Customized Workforce Training to Help Companies Effectively Foster Leadership Skills and Growth
-
NV5 to Host 2024 Investor Day: The Nexus of Engineering and Technology on Thursday, July 25th
-
SECOM Deploys Infinera XTM Series for Middle-mile Network to Bring New Broadband Services to Underserved Rural Colorado
-
Shirofune Releases Expanded Improvement Suggestion Feature for Amazon Ads
-
QXO Announces $620 Million Raised in New Private Placement
-
Pharma Two B Announces Plans to Go Public via Merger with Hepion Pharmaceuticals, Inc. and Concurrent $11.5 Million Private Placement
-
Sunrun Accelerates Momentum In Its New Homes Business With Addition of Two Top Industry Leaders
-
Kandi Technologies Announces First Taiwan-Made UTV Shipment to the U.S.
-
FinWise Bancorp Expands and Further Strengthens Board of Directors
-
aTyr Pharma Completes Enrollment in Global Pivotal Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis
-
Spectaire Announces Initial Delivery of a 500 AireCore Unit Order with $5 Million Annual Recurring Revenue Potential
-
Immutep Announces Successful Meeting with FDA on Phase III Design in Non-Small Cell Lung Cancer
-
Route 92 Medical Announces Commercial Launch of FreeClimb 88 Catheter System
-
Bitcoin Depot Exceeds Goal Deploying of 8,000 Bitcoin ATMs Five Months Ahead of Schedule
-
Arcutis to Host ZORYVE® (Roflumilast) Cream 0.15% FDA Approval Call With KOL
-
Meltwater partners with Blackbird.AI to combat narrative attacks created by the spread of misinformation and disinformation
-
Aspen University Announces the Distance Education Accrediting Commission has Vacated its Show Cause Directive Effective Immediately
-
AnewHealth Announces Strategic Investment from The Vistria Group and Acquisition of HomeFree
